Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
bluebird bio Announces First Quarter 2020 Earnings Conference Call and May Investor Event
12:01pm, Wednesday, 29'th Apr 2020
CAMBRIDGE, Mass. — bluebird bio, Inc. (NASDAQ: BLUE) today announced it will hold a conference call to discuss first quarter 2020 financial results and business updates on Monday, May 11 at 8…
bluebird bio Announces First Quarter 2020 Earnings Conference Call and May Investor Event
12:00pm, Wednesday, 29'th Apr 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced it will hold a conference call to discuss first quarter 2020 financial results and business updates on Monday, May 11 at 8:00 am ET.
How These 15 Stock Suggestions Fared Against the Market
04:44pm, Tuesday, 28'th Apr 2020
Motley Fool co-founder David Gardner revisits three Five-Stock Samplers and offers up lessons he learned to help you invest better.
Blue Light Radiation Emitted from Mobile Phones Can Damage Your Skin
04:06am, Tuesday, 28'th Apr 2020
Another thing to worry about: Using our digital devices can cause great damage to our skin because of blue light.
Stop Making Sense
01:28pm, Monday, 27'th Apr 2020
Not everything will make sense to everyone all of the time. Bear arguments make sense. Bull arguments make sense. The market will do what it will do. Set aside
Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains
08:05am, Monday, 27'th Apr 2020
As the market moves with COVID epidemiological data many stocks took a hit on questionable or incomplete news from the WHO on a clinical study in China on Remdesivir; Gilead Sciences stock took a hit
Ingalls & Snyder LLC Lowers Position in bluebird bio Inc (NASDAQ:BLUE)
09:36am, Saturday, 25'th Apr 2020
Ingalls & Snyder LLC cut its stake in shares of bluebird bio Inc (NASDAQ:BLUE) by 8.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor own
bluebird bio (NASDAQ:BLUE) Upgraded to Sell at BidaskClub
06:32am, Saturday, 25'th Apr 2020
BidaskClub upgraded shares of bluebird bio (NASDAQ:BLUE) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning, BidAskClub reports. A number of other res
Have Insiders Been Selling bluebird bio, Inc. (NASDAQ:BLUE) Shares?
02:16pm, Wednesday, 22'nd Apr 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
bluebird bio (BLUE) Catches Eye: Stock Jumps 6%
12:51pm, Monday, 20'th Apr 2020
bluebird bio (BLUE) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
bluebird bio (BLUE) Catches Eye: Stock Jumps 6%
12:51pm, Monday, 20'th Apr 2020
bluebird bio (BLUE) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Arden Trust Co Makes New $105,000 Investment in bluebird bio Inc (NASDAQ:BLUE)
09:14am, Monday, 20'th Apr 2020
Arden Trust Co acquired a new position in shares of bluebird bio Inc (NASDAQ:BLUE) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,2
Financial Analysis: Pharmacyte Biotech (OTCMKTS:PMCB) vs. bluebird bio (OTCMKTS:BLUE)
08:34am, Monday, 20'th Apr 2020
bluebird bio (NASDAQ:BLUE) and Pharmacyte Biotech (OTCMKTS:PMCB) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividen
Brokerages Expect bluebird bio Inc (NASDAQ:BLUE) Will Post Quarterly Sales of $8.84 Million
07:38am, Monday, 20'th Apr 2020
Analysts expect bluebird bio Inc (NASDAQ:BLUE) to post $8.84 million in sales for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have provided estimates for bluebird
